Literature DB >> 7862445

p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.

A Hartmann1, H Blaszyk, R M McGovern, J J Schroeder, J Cunningham, E M De Vries, J S Kovach, S S Sommer.   

Abstract

Most studies of mutations in the p53 tumor suppressor gene in tumors have examined only exons 5-8. Our laboratory previously found 64 mutations in exons 5-8 of the p53 gene in 194 primary breast cancers. Herein, we report 18 additional mutations found outside of exons 5-8. Mutations are present in exons 4, 9 and 10, and flanking splice junctions, but not in the promotor region or in exons 1, 2, 3 and 11. No missense mutations are found outside of exons 5-8. Instead, there is a predominance of frameshift mutations with lesser numbers of nonsense and splice site mutations. In contrast, the majority of mutations in exons 5-8 in this sample are missense changes and all of these are at amino acids that are identical in the 11 known p53 sequences that represent about 1.6 billion years of evolutionary divergence. The difference in mutational pattern between these two regions of the p53 gene is due to a lack of missense mutations and inframe microdeletions outside of exons 5-8. A review of our database of p53 mutations (De Vries et al., in preparation) shows that the patterns of mutation inside and outside of exons 5-8 differ in other types of cancers as well. The paucity of missense mutations in exons 2-4 and 9-11 in breast and other cancers (even at amino acids identical throughout p53 gene evolution) suggest that at least some missense mutations result in a phenotype other than malignant transformation. These data also illustrate the importance of examining identical exons when comparing the pattern of p53 gene mutations in different populations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7862445

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer.

Authors:  Shunichi Tsujitani; Hiroaki Saito; Toshiro Wakatsuki; Masahide Ikeguchi; Ken Shirabe; Masaru Morita; Yoshihiro Kakeji; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-12-06       Impact factor: 2.549

2.  p53 gene alterations and protein accumulation in colorectal cancer.

Authors:  R Bertorelle; G Esposito; C Belluco; L Bonaldi; A Del Mistro; D Nitti; M Lise; L Chieco-Bianchi
Journal:  Clin Mol Pathol       Date:  1996-04

3.  Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities.

Authors:  Pascal Andujar; Céline Lecomte; Annie Renier; Jocelyne Fleury-Feith; Laurence Kheuang; Julien Daubriac; Anne Janin; Marie-Claude Jaurand
Journal:  Carcinogenesis       Date:  2007-02-01       Impact factor: 4.944

Review 4.  TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.

Authors:  Ashkan Shahbandi; Hoang D Nguyen; James G Jackson
Journal:  Trends Cancer       Date:  2020-02-05

5.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

6.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

7.  A polymorphism but no mutations in the GADD45 gene in breast cancers.

Authors:  H Blaszyk; A Hartmann; S S Sommer; J S Kovach
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

8.  p53 and follow-up of colorectal adenocarcinomas.

Authors:  A Polge; J F Bourgaux; E Bancel; C Pignodel; J C Boyer; S Poirey; B M de Bornier; J L Balmes; J P Bali
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

9.  Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

Authors:  J S Kovach; A Hartmann; H Blaszyk; J Cunningham; D Schaid; S S Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

10.  Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

Authors:  F Ganci; A Sacconi; N Bossel Ben-Moshe; V Manciocco; I Sperduti; L Strigari; R Covello; M Benevolo; E Pescarmona; E Domany; P Muti; S Strano; G Spriano; G Fontemaggi; G Blandino
Journal:  Ann Oncol       Date:  2013-10-09       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.